Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100746243 | 10074624 | 3 | F | 20160913 | 20140414 | 20160915 | EXP | US-ROCHE-1380311 | ROCHE | 0.00 | F | Y | 0.00000 | 20160915 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100746243 | 10074624 | 1 | PS | AVASTIN | BEVACIZUMAB | 1 | Unknown | 125085 | |||||||||||
| 100746243 | 10074624 | 2 | SS | LUCENTIS | RANIBIZUMAB | 1 | Unknown | 125156 | SOLUTION FOR INJECTION | ||||||||||
| 100746243 | 10074624 | 3 | C | EYLEA | AFLIBERCEPT | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 100746243 | 10074624 | 1 | Neovascular age-related macular degeneration |
| 100746243 | 10074624 | 2 | Neovascular age-related macular degeneration |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 100746243 | 10074624 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 100746243 | 10074624 | Blindness | |
| 100746243 | 10074624 | Cerebrovascular accident | |
| 100746243 | 10074624 | Drug ineffective | |
| 100746243 | 10074624 | Dry eye |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |